Catherine Stehman-Breen is the founder of Chroma Medicine. Chroma Medicine has raised $260M in total funding. Latest round: Series B. Backed by GV.
Catherine Stehman-Breen is the co-founder and CEO of Chroma Medicine, a genomic medicine company focused on epigenetic editing. She is also a faculty member in Epidemiology at the University of Washington. Under her leadership, Chroma Medicine has raised significant funding, including a $125 million Series A and a $135 million Series B.
Full founder directory · Investor directory · Company funding database · Fundraising library